Published in Dokl Akad Nauk on January 01, 1992
Why the smallpox virus stocks should not be destroyed. Science (1993) 1.56
Human monkeypox and smallpox viruses: genomic comparison. FEBS Lett (2001) 1.32
Analysis of the monkeypox virus genome. Virology (2002) 1.27
Genes of variola and vaccinia viruses necessary to overcome the host protective mechanisms. FEBS Lett (1993) 1.23
Synthesis and selective vasodilating properties of esters of 2,6-dimethyl-4-(2-difluoromethoxyphenyl)-1,4-dihydro-pyridine-3,5-di- carboxylic acid. Arzneimittelforschung (1989) 1.07
CombiHIVvac vaccine which contains polyepitope B and T- cell immunogens of HIV-1. Dokl Biochem Biophys (2007) 0.95
DNA-polycation complexes: effect of polycation structure on physico-chemical and biological properties. J Biotechnol (2006) 0.94
Comparison of the genetic maps of variola and vaccinia viruses. FEBS Lett (1993) 0.93
Analysis of the nucleotide sequence of 53 kbp from the right terminus of the genome of variola major virus strain India-1967. Virus Res (1994) 0.92
Ankyrin-like proteins of variola and vaccinia viruses. FEBS Lett (1993) 0.91
Amyloidogenic peptide homologous to beta-domain region of alpha-lactalbumin. Dokl Biochem Biophys (2007) 0.89
[The anti-HIV activity of beta-glycyrrhizic acid]. Vopr Virusol (1993) 0.89
Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein. Biochemistry (Mosc) (2012) 0.88
Analysis of the nucleotide sequence of 23.8 kbp from the left terminus of the genome of variola major virus strain India-1967. Virus Res (1996) 0.88
Fluorinated derivatives of benz[4,5]imidazo[1,2-b][1,3] thiazole--inhibitors of reproduction of measles virus. Dokl Biochem Biophys (2004) 0.87
[The detection and quantitative determination of antigens to the human immunodeficiency virus types 1 and 2]. Vopr Virusol (1992) 0.86
[Primary structure of the DNA copy of the protein VP1 gene of the foot-and-mouth disease virus A22]. Bioorg Khim (1986) 0.85
[The characteristics of the long-term continuous cultivation of a cell line chronically infected with the human immunodeficiency virus type-1]. Vopr Virusol (1992) 0.84
Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein. Tuberculosis (Edinb) (2006) 0.84
Design of immunogens as components of a new generation of molecular vaccines. J Biotechnol (1996) 0.83
Construction of an artificial immunogen, a candidate DNA vaccine encoding multiple CTL epitopes of HIV-1. Dokl Biochem Biophys (2004) 0.83
[New recombinant variant of human immunodeficiency virus of type 1, subtype envB/envA, isolated in Novosibirsk]. Zh Mikrobiol Epidemiol Immunobiol (2004) 0.83
[Analysis of pandemic influenza in Russia as a part of the global process based on data of an influenza monitoring reference center]. Zh Mikrobiol Epidemiol Immunobiol (2011) 0.83
Amplification of DNA sequences of Epstein-Barr and human immunodeficiency viruses using DNA-polymerase from Thermus thermophilus. Mol Cell Probes (1990) 0.82
Multiple genetic differences between the monkeypox and variola viruses. Dokl Biochem Biophys (2002) 0.82
Highly pathogenic influenza virus H5N1 found in western Siberia is genetically related to viruses that circulated in Southeast Asia in 2003-2005. Dokl Biol Sci (2006) 0.82
[The effect of peptides-analogs of T4 receptor and HLA class II antigens on the reproduction of human immunodeficiency virus]. Dokl Akad Nauk SSSR (1990) 0.82
[The 2009 pandemic influenza in Russia. I. Diagnosis and molecular biological characteristics of the virus]. Vopr Virusol (2011) 0.81
[Comparison of the amino acid sequence of structural proteins from attenuated and pathogenic strains of the Venezuelan equine encephalomyelitis virus]. Dokl Akad Nauk SSSR (1991) 0.81
Atomic force microscopy study of peptides homologous to beta-domain of alpha-lactalbumins. Protein Pept Lett (2007) 0.81
[Cowpea mosaic virus chimeric particles bearing ectodomain of matrix protein 2 (M2E) of influenza A virus: production and characteristics]. Mol Biol (Mosk) (2009) 0.81
[Entire coding sequence of the variola virus]. Dokl Akad Nauk (1993) 0.81
[Experimental study of Ebola hemorrhagic fever in baboon models]. Biull Eksp Biol Med (1995) 0.81
Modulation of inflammatory response improves myocardial infarct healing in rats. Curr Pharm Des (2014) 0.81
[Antiviral activity of several vasodilator agents]. Biull Eksp Biol Med (1996) 0.81
[Tandem bifunctional derivatives of short oligonucleotides--inhibitors of replication of the human immunodeficiency virus in cell culture]. Mol Biol (Mosk) (1999) 0.80
DNA sequencing with thermostable Tet DNA polymerase from Thermus thermophilus. Nucleic Acids Res (1989) 0.80
[Production of a viable variant of the M13 phage with a foreign peptide inserted into the basic coat protein]. Dokl Akad Nauk SSSR (1989) 0.80
Recombinant influenza vaccines. Acta Naturae (2012) 0.80
[Detection of unintegrated forms of proviral DNA in HIV infections]. Vestn Ross Akad Med Nauk (1998) 0.80
[Study of the structure-activity organization of the smallpox viral genome. V. Sequencing and analysis of the nucleotide sequence of the left terminus of the India-1967 strain genome]. Mol Biol (Mosk) (1996) 0.79
Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis. J Biotechnol (1996) 0.79
Inhibition of HIV proliferation in MT-4 cells by antisense oligonucleotide conjugated to lipophilic groups. Biochimie (1993) 0.79
The efficacy of cell therapy in the treatment of patients with trophic venous ulcers of the lower limbs. Angiol Sosud Khir (2007) 0.79
[Secondary structure of the M2 protein of influenza type A virus and its role in forming resistance to rimantadine and deitiforin]. Mol Biol (Mosk) (1995) 0.79
[Molecular characteristic of influenza virus A H5N1 Strains isolated from poultry in Kurgan Region in 2005]. Mol Biol (Mosk) (2008) 0.78
[Content of progesterone, glucocorticoid and glycyrrhizic acid receptors in normal and tumoral human breast tissue]. Vopr Onkol (1998) 0.78
[Localization of the HIV-1 gp120 conformational epitope recognized by virus neutralizing monoclonal antibodies 2G12]. Mol Biol (Mosk) (2002) 0.78
[Universal diagnostic oligonucleotide microarray for subtyping of human and animal influenza A viruses]. Vopr Virusol (2014) 0.78
A test for the "degeneracy" of valine-acceptor ribonucleic acid. Biochim Biophys Acta (1965) 0.78
[Activation of free radicals reaction and changes in the state of antioxidant protection in blood in toxic experimental influenza infection]. Biull Eksp Biol Med (1992) 0.78
[Preparation of enriched valine-acceptor soluble RNA from baker's yeasts]. Dokl Akad Nauk SSSR (1965) 0.78
[A preparative procedure for the isolation of enriched preparations of aminoacyl-tRNA-synthetases from baker's yeast]. Biokhimiia (1968) 0.78
Development of a candidate polyvalent live vaccine against human immunodeficiency, hepatitis B, and orthopox viruses. Dokl Biochem Biophys (2003) 0.78
Comparative assessment of the properties of orthopoxviral soluble receptors for tumor necrosis factor. Dokl Biochem Biophys (2003) 0.78
Species-specific differences in the organization of the complement-binding protein of orthopoxviruses. Dokl Biochem Biophys (2001) 0.77
[In vitro and in vivo effects of ingavirin on the ultrastructure and infectivity of influenza virus]. Vopr Virusol (2011) 0.77
[Antiviral activity of Ingavirin in experimental lethal influenza due to influenza virus B in albino mice]. Antibiot Khimioter (2010) 0.77
[Effect of mutations in genes of Venezuelan equine encephalomyelitis virus structural proteins on its attenuation]. Dokl Akad Nauk (1992) 0.77
[Experimental study of Ingavirin antiviral activity against human adenovirus]. Antibiot Khimioter (2010) 0.77
Species-specific differences in the organization of genes encoding kelch-like proteins of orthopoxviruses pathogenic for humans. Dokl Biochem Biophys (2002) 0.77
Development of Recombinant Vaccine against A(H1N1) 2009 Influenza Based on Virus-like Nanoparticles Carrying the Extracellular Domain of M2 Protein. Acta Naturae (2010) 0.77
[Inhibition of Marburg virus reproduction by glycyrrhizinic acid and its derivatives]. Dokl Akad Nauk (1995) 0.77
Phylogenetic comparison of the genomes of different strains of variola virus. Dokl Biochem Biophys (2004) 0.77
Fatty acid acylated antibodies against virus suppress its reproduction in cells. FEBS Lett (1989) 0.77
[Effect of different water-soluble forms of the fullerene C60 on the metabolic activity and ultra-structure of cells in culture]. Biofizika (2012) 0.77
[Study of tolerability and reactogenicity of pandemic vaccines against influenza type A/H1N1]. Zh Mikrobiol Epidemiol Immunobiol (2010) 0.77
Inserting foreign peptides into the major coat protein of bacteriophage M13. FEBS Lett (1992) 0.77
Symptoms of infection caused by SARS coronavirus in laboratory mice and guinea pigs. Dokl Biol Sci (2004) 0.77
[Protective activity of Ingavirin in experimental lethal influenza due to pandemic influenza virus A (H1N1)v in albino mice]. Antibiot Khimioter (2010) 0.77
[Antiaggregant properties of new 1,3,4-thiadiazine derivatives]. Eksp Klin Farmakol (2009) 0.77
[Influence of new 1,3,4-thiadiazines on platelet aggregation in vitro and ex vivo]. Eksp Klin Farmakol (2010) 0.76
[Human mini-antibodies to orthopoxviruses]. Vestn Ross Akad Med Nauk (2004) 0.76
[The anti-HIV activity of glycyrrhizic acid penta-O-nicotinate]. Vestn Ross Akad Med Nauk (2004) 0.76
[The structural and functional analysis of the biological activity of acridine derivatives]. Vestn Ross Akad Med Nauk (2004) 0.76
[Experimental investigation of Ingavirin antiviral activity against human parainfluenza virus]. Antibiot Khimioter (2010) 0.76
[Reconstruction of autonomic genetic and protein-synthesizing systems from viral RNA and isolated mitochondria]. Dokl Akad Nauk SSSR (1971) 0.76
[Universal influenza vaccines: developments, prospects for use]. Vopr Virusol (2012) 0.76
[Immunogenetic properties of peptides mimicking a human immunodeficiency virus gp41 (HIV-1) epitope recognized by virus-neutralizing antibody 2F5]. Mol Biol (Mosk) (2003) 0.76
[Nucleotide sequence of genes and complete amino acid sequence of tick-borne encephalitis virus strain 205]. Mol Gen Mikrobiol Virusol (1991) 0.76
Insulin fibrillogenesis in vitro. Dokl Biochem Biophys (2008) 0.76
[Development of the anti-influenza H5N1 vaccines worldwide and in Russia]. Zh Mikrobiol Epidemiol Immunobiol (2006) 0.76
Mutant human gamma-interferon with a truncated C-terminus and its properties. Dokl Biochem (2000) 0.76
The full-length recombinant human antibody to vaccinia virus. Dokl Biochem Biophys (2006) 0.76
[Influence of rimantadine, ribavirine and triazavirine on influenza A virus replication in human monolayer and lymphoblastoid cell lines]. Antibiot Khimioter (2011) 0.75
[Radiation modulating properties of derivates of 1,4-dihydropyridine and 1,2,3,4,5,6,7,8,9,10-decahydroacridine-1,8 dione]. Radiats Biol Radioecol (2004) 0.75
[A new skin radioprotective agent Diethon (experimental study)]. Radiobiol Radiother (Berl) (1990) 0.75
[Cardioprotective properties of a 1,4-dihydropyridine derivative, glutapyrone, in deep hypothermia]. Biull Eksp Biol Med (1989) 0.75
[Regulation of peroxidation of mitochondrial membrane lipids initiated by Fe2+ ions by antoxidants of the 1,4-dihydropyridine series in experiments in vitro]. Vopr Med Khim (1977) 0.75
[Antiviral action of some antioxidants/antihypoxants and their combinations with remantadine against human influenza A(H3N2) virus studied in in vitro models]. Eksp Klin Farmakol (2007) 0.75